Brief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Yesterday 02:22
BRIEF-BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M Oct 21 (Reuters) - BLS Pharmaceuticals Limited BLS.AX:
Q1 FY27 REVENUE A$26.7M
Further company coverage: BLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN